Elan Corp. (ELN) announced Monday morning that it has received a proposal from Royalty Pharma to be acquired for US$11 for every Elan Share and every Elan ADS.
Elan has gapped open sharply higher this morning and is now up 0.93 at $11.53 on above average volume. The stock has risen to a 5-month high and has re-crossed its 200-day moving average.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org